Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment

Matthew Anaka, Omar Abdel-Rahman Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, CanadaCorrespondence: Omar Abdel-RahmanDepartment of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada, Tel +1 780-432-8...

Full description

Bibliographic Details
Main Authors: Anaka M, Abdel-Rahman O
Format: Article
Language:English
Published: Dove Medical Press 2022-01-01
Series:Cancer Management and Research
Subjects:
fluoropyrimidine
chemotherapy
adverse events
capecitabine
fluorouracil.
Online Access:https://www.dovepress.com/managing-5fu-cardiotoxicity-in-colorectal-cancer-treatment-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/managing-5fu-cardiotoxicity-in-colorectal-cancer-treatment-peer-reviewed-fulltext-article-CMAR

Similar Items